-
1
-
-
56549085764
-
Unacceptable variation in abdominoperineal excision rates for rectal cancer: Time to intervene?
-
Morris E, Quirke P, Thomas JD, et al. Unacceptable variation in abdominoperineal excision rates for rectal cancer: time to intervene? Gut 2008; 57 (12): 1690-7.
-
(2008)
Gut
, vol.57
, Issue.12
, pp. 1690-7
-
-
Morris, E.1
Quirke, P.2
Thomas, J.D.3
-
2
-
-
0022466378
-
Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision
-
Quirke P, Durdey P, Dixon MF, et al. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection: histopathological study of lateral tumour spread and surgical excision. Lancet 1986; II: 996-9. (Pubitemid 16005611)
-
(1986)
Lancet
, vol.2
, Issue.8514
, pp. 996-999
-
-
Quirke, P.1
Dixon, M.F.2
Durdey, P.3
Williams, N.S.4
-
3
-
-
0031852766
-
Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent: Predictor of survival but not local recurrence?
-
DOI 10.1007/BF02237384
-
Hall NR, Finan PJ, al-Jaberi T, et al. Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent: predictor of survival but not local recurrence? Dis Colon Rectum 1998; 41 (8): 979-83. (Pubitemid 28369285)
-
(1998)
Diseases of the Colon and Rectum
, vol.41
, Issue.8
, pp. 979-983
-
-
Hall, N.R.1
Finan, P.J.2
Al-Jaberi, T.3
Tsang, C.S.4
Brown, S.R.5
Dixon, M.F.6
Quirke, P.7
-
4
-
-
21244492845
-
Comparison of circumferential margin involvement between restrorative and nonrestorative resections for rectal cancer
-
DOI 10.1111/j.1463-1318.2005.00767.x
-
Tekkis PP, Heriot AG, Smith J, et al. Association of Coloproctology of Great Britain and Ireland. Comparison of circumferential margin involvement between restorative and nonrestorative resections for rectal cancer. Colorectal Dis 2005; 7 (4): 369-74. (Pubitemid 40894866)
-
(2005)
Colorectal Disease
, vol.7
, Issue.4
, pp. 369-374
-
-
Tekkis, P.P.1
Heriot, A.G.2
Smith, J.3
Thompson, M.R.4
Finan, P.5
Stamatakis, J.D.6
-
5
-
-
34547808450
-
Quality of surgery in T3-4 rectal cancer: Involvement of circumferential resection margin not influenced by preoperative treatment. Results from EORTC trial 22921
-
DOI 10.1016/j.ejca.2007.05.025, PII S0959804907004388
-
den Dulk M, Collette L, van de Velde CJ, et al., EORTC Radiation Oncology Group. Quality of surgery in T3-4 rectal cancer: involvement of circumferential resection margin not influenced by preoperative treatment: results fromEORTCtrial 22921. Eur JCancer 2007; 43 (12): 1821-8. (Pubitemid 47241247)
-
(2007)
European Journal of Cancer
, vol.43
, Issue.12
, pp. 1821-1828
-
-
Den Dulk, M.1
Collette, L.2
Van De Velde, C.J.H.3
Marijnen, C.A.M.4
Calais, G.5
Mineur, L.6
Maingon, P.7
Radosevic-Jelic, L.8
Daban, A.9
Bosset, J.-F.10
-
6
-
-
0023836214
-
Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: Results from NSABP protocol R-01
-
Fisher B, Wolmark N, Rockette H, et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst 1988; 80 (1): 21-9. (Pubitemid 18076565)
-
(1988)
Journal of the National Cancer Institute
, vol.80
, Issue.1
, pp. 21-29
-
-
Fisher, B.1
Wolmark, N.2
Rockette, H.3
Redmond, C.4
Deutsch, M.5
Wickerman, D.L.6
Fisher, E.R.7
Caplan, R.8
Jones, J.9
Lerner, H.10
Gordon, P.11
Feldman, M.12
Cruz, A.13
Legault-Poisson, S.14
Wexler, M.15
Lawrence, W.16
Robidoux, A.17
-
7
-
-
0021792174
-
Prolongation of the disease-free survival in surgically treated rectal carcinoma
-
Gastrointestinal Tumor Study Group
-
Gastrointestinal Tumor Study Group. Prolongation of the disease-free survival in surgically treated rectal carcinoma. N Engl J Med 1985; 312: 1465-72.
-
(1985)
N Engl J Med
, vol.312
, pp. 1465-1472
-
-
-
8
-
-
0026071185
-
Effective surgical adjuvant therapy for high-risk rectal carcinoma
-
Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991; 324: 709-15.
-
(1991)
N Engl J Med
, vol.324
, pp. 709-715
-
-
Krook, J.E.1
Moertel, C.G.2
Gunderson, L.L.3
-
9
-
-
6044226542
-
Preoperative versus postoperative chemoradiotherapy for rectal cancer
-
German Rectal Cancer Study Group
-
Sauer R, Becker H, Hohenberger W, et al., German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl JMed 2004; 351: 1731-40.
-
(2004)
N Engl JMed
, vol.351
, pp. 1731-1740
-
-
Sauer, R.1
Becker, H.2
Hohenberger, W.3
-
10
-
-
1842377447
-
Improved survival with preoperative radiotherapy in resectable cancer
-
The Swedish Rectal Cancer Trial
-
The Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable cancer. N Engl J Med 1997; 336 (14): 980-7.
-
(1997)
N Engl J Med
, vol.336
, Issue.14
, pp. 980-7
-
-
-
11
-
-
0035975394
-
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer
-
Dutch Colorectal Cancer Group
-
Kapiteijn E, Marijnen CA, Nagtegaal ID, et al., Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345 (9): 638-46.
-
(2001)
N Engl J Med
, vol.345
, Issue.9
, pp. 638-646
-
-
Kapiteijn, E.1
Marijnen, C.A.2
Nagtegaal, I.D.3
-
12
-
-
34548557656
-
The TME trial after a median follow-up of 6 years: Increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma
-
DOI 10.1097/01.sla.0000257358.56863.ce, PII 0000065820071100000001
-
Peeters KC, Marijnen CA, Nagtegaal ID, et al., for the Dutch Colorectal Cancer Group. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007; 246 (5): 693-701. (Pubitemid 350035641)
-
(2007)
Annals of Surgery
, vol.246
, Issue.5
, pp. 693-701
-
-
Peeters, K.C.M.J.1
Marijnen, C.A.M.2
Nagtegaal, I.D.3
Kranenbarg, E.K.4
Putter, H.5
Wiggers, T.6
Rutten, H.7
Pahlman, L.8
Glimelius, B.9
Leer, J.W.10
Van De Velde, C.J.H.11
-
13
-
-
61349188341
-
Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): A multicentre, randomised trial
-
Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 2009; 373 (9666): 811-20.
-
(2009)
Lancet
, vol.373
, Issue.9666
, pp. 811-820
-
-
Sebag-Montefiore, D.1
Stephens, R.J.2
Steele, R.3
-
14
-
-
61349086080
-
Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: A prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial
-
MRC CR07/NCICCTG CO16 Trial Investigators; NCRI Colorectal Cancer Study Group
-
Quirke P, Steele R, Monson J, et al., MRC CR07/NCICCTG CO16 Trial Investigators; NCRI Colorectal Cancer Study Group. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet 2009; 373 (9666): 821-8.
-
(2009)
Lancet
, vol.373
, Issue.9666
, pp. 821-8
-
-
Quirke, P.1
Steele, R.2
Monson, J.3
-
15
-
-
0030583839
-
Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer
-
Medical Research Council Rectal Cancer Working Party Medical Research Council Rectal Cancer Working Party
-
Medical Research Council Rectal Cancer Working Party. Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Medical Research Council Rectal Cancer Working Party. Lancet 1996; 348 (9042): 1605-10.
-
(1996)
Lancet
, vol.348
, Issue.9042
, pp. 1605-1610
-
-
-
16
-
-
0025349174
-
Preoperative short-term radiation therapy in operable rectal carcinoma: A prospective randomized trial
-
Stockholm Rectal Cancer Study Group
-
Stockholm Rectal Cancer Study Group. Preoperative short-term radiation therapy in operable rectal carcinoma: a prospective randomized trial. Cancer 1990; 66 (1): 49-55.
-
(1990)
Cancer
, vol.66
, Issue.1
, pp. 49-55
-
-
-
17
-
-
0025690213
-
Low-dose preoperative radiation postpones recurrences in operable rectal cancer: Results of a randomizedmulticenter trial inwesternNorway
-
Dahl O, Horn A, Morild I, et al. Low-dose preoperative radiation postpones recurrences in operable rectal cancer: results of a randomizedmulticenter trial inwesternNorway. Cancer 1990; 66 (11): 2286-94.
-
(1990)
Cancer
, vol.66
, Issue.11
, pp. 2286-2294
-
-
Dahl, O.1
Horn, A.2
Morild, I.3
-
18
-
-
0025139938
-
Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial
-
Pahlman L, Glimelius B. Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma: report from a randomized multicenter trial. Ann Surg 1990; 211 (2): 187-95. (Pubitemid 20063206)
-
(1990)
Annals of Surgery
, vol.211
, Issue.2
, pp. 187-195
-
-
Pahlman, L.1
Glimelius, B.2
-
19
-
-
70449726857
-
Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP-R03
-
Roh MS, Colangelo LH, O'Connell MJ, et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP-R03. J Clin Oncol 2009; 27: 5124-30.
-
(2009)
J Clin Oncol
, vol.27
, pp. 5124-5130
-
-
Roh, M.S.1
Colangelo, L.H.2
O'Connell, M.J.3
-
20
-
-
0021186104
-
Final results of a randomised trial on the treatment of rectal cancer with pre-operative radiotherapy alone or in combination with 5 fluorouracil followed by radical surgery
-
Boulis-Wassif S, Gerrard A, Loygue J, et al. Final results of a randomised trial on the treatment of rectal cancer with pre-operative radiotherapy alone or in combination with 5 fluorouracil followed by radical surgery. Cancer 1984; 53: 1811-8.
-
(1984)
Cancer
, vol.53
, pp. 1811-8
-
-
Boulis-Wassif, S.1
Gerrard, A.2
Loygue, J.3
-
21
-
-
33748676449
-
Chemotherapy with preoperative radiotherapy in rectal cancer
-
DOI 10.1056/NEJMoa060829
-
Bosset JF, Collette L, Calais G, et al. Chemoradiotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006; 355: 1114-23. (Pubitemid 44394918)
-
(2006)
New England Journal of Medicine
, vol.355
, Issue.11
, pp. 1114-1123
-
-
Bosset, J.-F.1
Collette, L.2
Calais, G.3
Mineur, L.4
Maingon, P.5
Radosevic-Jelic, L.6
Daban, A.7
Bardet, E.8
Beny, A.9
Ollier, J.-C.10
-
22
-
-
33750580102
-
Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD 9203
-
DOI 10.1200/JCO.2006.06.7629
-
Gerard JP, Conroy T, Bonnetain F, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-T4 rectal cancers: results of FFCD 9203. J Clin Oncol 2006; 24: 4620-5. (Pubitemid 46630960)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.28
, pp. 4620-4625
-
-
Gerard, J.-P.1
Conroy, T.2
Bonnetain, F.3
Bouche, O.4
Chapet, O.5
Closon-Dejardin, M.-T.6
Untereiner, M.7
Leduc, B.8
Francois, E.9
Maurel, J.10
Seitz, J.-F.11
Buecher, B.12
Mackiewicz, R.13
Ducreux, M.14
Bedenne, L.15
-
23
-
-
3242716904
-
Sphincter preservation following preoperative radiotherapy for rectal cancer: Report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy
-
DOI 10.1016/j.radonc.2003.12.006, PII S0167814004000040
-
Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al. Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomized trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol 2004; 72: 15-24. (Pubitemid 38952855)
-
(2004)
Radiotherapy and Oncology
, vol.72
, Issue.1
, pp. 15-24
-
-
Bujko, K.1
Nowacki, M.P.2
Nasierowska-Guttmejer, A.3
Michalski, W.4
Bebenek, M.5
Pudelko, M.6
Kryj, M.7
Oledzki, J.8
Szmeja, J.9
Sluszniak, J.10
Serkies, K.11
Kladny, J.12
Pamucka, M.13
Kukolowicz, P.14
-
24
-
-
21244494450
-
Postoperative complications in patients irradiated pre-operatively for rectal cancer: Report of a randomised trial comparing short-term radiotherapy vs chemoradiation
-
DOI 10.1111/j.1463-1318.2005.00796.x
-
Bujko K, Nowacki MP, Kepka L, et al. Postoperative complications in patients irradiated pre-operatively for rectal cancer: report of a randomised trial. Comparing short-term radiotherapy vs chemoradiation. Colorect Dis 2005; 7: 410-6. (Pubitemid 40894874)
-
(2005)
Colorectal Disease
, vol.7
, Issue.4
, pp. 410-416
-
-
Bujko, K.1
Nowacki, M.P.2
Kepka, L.3
Oledzki, J.4
Bebenek, M.5
Kryj, M.6
Bednarczyk, M.7
Chwalinski, M.8
Dziewiecki, A.9
Jaskola, K.10
Kosakowska, E.11
Kukawski, P.12
Liszka-Dalecki, P.13
Michalski, W.14
Nasierowska-Guttmejer, A.15
Nawrocki, G.16
Piotrowski, P.17
Sikora, D.18
Sopylo, R.19
Zawadzka, B.20
Andziak, P.21
Ziembinski, A.22
Biejat, Z.23
Polanski, J.24
Gornicka, B.25
Krasnodebski, I.26
Slodkowski, M.27
Chmielarz, A.28
Chmielik, E.29
Maciejewski, B.30
Maka, B.31
Nowicka, E.32
Plewicki, G.33
Poltorak, S.34
Samborska-Plewicka, M.35
Straczynski, M.36
Suwinski, R.37
Walichiewicz, P.38
Widel, M.39
Wydmanski, J.40
Osuch, C.41
Richter, P.42
Skibinski, J.43
Darasz, Z.44
Herman, K.45
Kowalska, T.46
Reinfuss, M.47
Rys, J.48
Stelmach, A.49
Al-Amawi, T.50
Husarski, T.51
Kozlowski, M.52
Jarema, A.53
Kladny, J.54
Rogowska, D.55
Fundowicz, D.56
Lozinski, C.57
Murawa, P.58
Nowakowski, W.59
Stryczynska, G.60
Teresiak, M.61
Drews, M.62
Kedziora, R.63
Majewski, P.64
Meissner, P.65
Szmeja, J.66
Pudelko, M.67
Szulc, R.68
Winkler-Spytkowska, B.69
Wojnar, A.70
Pamucka, M.71
Redelbach, W.72
Sachambinski, A.73
Szudrowicz, Z.74
Tokar, P.75
Florek, A.76
Gebski, A.77
Gluszek, S.78
Gozdz, S.79
Kedzierawski, P.80
Korejba, W.81
Kucharczyk, D.82
Kukolowicz, P.83
Ostrowski, M.84
Sadowski, J.85
Salata, A.86
Sluszniak, J.87
Sygut, J.88
Wieczorek, A.89
Zielinski, A.90
Chmielewska-Pytka, B.91
Harezga, B.92
Pawlak, M.93
Bocian, R.94
Cywinski, J.95
more..
-
25
-
-
77956686410
-
Arandomized trial comparing local recurrence (LR) rates between short-course (SC) and long-course (LC) preoperative radiotherapy (RT) for clinical T3 rectal cancer: An intergroup trial (TROG, AGITG, CSSANZ, RACS) [abstract no. 3509]
-
TROG, AGITG, CSSANZ, and RACS
-
Ngan S, Fisher R, Goldstein D, et al. TROG, AGITG, CSSANZ, and RACS. Arandomized trial comparing local recurrence (LR) rates between short-course (SC) and long-course (LC) preoperative radiotherapy (RT) for clinical T3 rectal cancer: an intergroup trial (TROG, AGITG, CSSANZ, RACS) [abstract no. 3509]. J Clin Oncol 2010; 28 (15 Suppl.): 3509.
-
(2010)
J Clin Oncol
, vol.28
, Issue.15 SUPPL.
, pp. 3509
-
-
Ngan, S.1
Fisher, R.2
Goldstein, D.3
-
26
-
-
62249096271
-
Preoperative short-course radiotherapy versus combined radiochemotherapy in locally advanced rectal cancer: A multi-centre prospectively randomised study of the Berlin Cancer Society
-
Siegel R, Burock S, Wernecke KD, et al. Preoperative short-course radiotherapy versus combined radiochemotherapy in locally advanced rectal cancer: a multi-centre prospectively randomised study of the Berlin Cancer Society. BMC Cancer 2009; 9: 50.
-
(2009)
BMC Cancer
, vol.9
, pp. 50
-
-
Siegel, R.1
Burock, S.2
Wernecke, K.D.3
-
27
-
-
34447254462
-
Sphincter preserving surgery after preoperative treatment for ultra-low rectal carcinoma: A French multicenter prospective trial: GRECCAR 1 [abstract]
-
Rouanet P, Rivoire M, Lelong B, et al. Sphincter preserving surgery after preoperative treatment for ultra-low rectal carcinoma: a French multicenter prospective trial: GRECCAR 1 [abstract]. J Clin Oncol 2006; 24 (18 Suppl.): 3527.
-
(2006)
J Clin Oncol
, vol.24
, Issue.18 SUPPL.
, pp. 3527
-
-
Rouanet, P.1
Rivoire, M.2
Lelong, B.3
-
28
-
-
17344384995
-
Combined chemo- and radiotherapy vs. radiotherapy alone in the treatment of primary, nonresectable adenocarcinoma of the rectum
-
Frykholm GJ, Pahlman L, Glimerlius B. Combined chemo- and radiotherapy vs. radiotherapy alone in the treatment of primary, nonresectable adenocarcinoma of the rectum. Int J Radiat Oncol Biol Phys 2001; 50 (2): 427-34.
-
(2001)
Int J Radiat Oncol Biol Phys
, vol.50
, Issue.2
, pp. 427-434
-
-
Frykholm, G.J.1
Pahlman, L.2
Glimerlius, B.3
-
29
-
-
49249090949
-
Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer
-
Braendengen M, Tveit KM, Berglund A, et al. Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol 2008; 26 (22): 3687-94.
-
(2008)
J Clin Oncol
, vol.26
, Issue.22
, pp. 3687-3694
-
-
Braendengen, M.1
Tveit, K.M.2
Berglund, A.3
-
30
-
-
33748433241
-
Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer
-
DOI 10.1002/bjs.5506
-
Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al. Long-term results of a randomised trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006; 93: 1215-23. (Pubitemid 44547018)
-
(2006)
British Journal of Surgery
, vol.93
, Issue.10
, pp. 1215-1223
-
-
Bujko, K.1
Nowacki, M.P.2
Nasierowska-Guttmejer, A.3
Michalski, W.4
Bebenek, M.5
Kryj, M.6
-
31
-
-
39749153032
-
Phase I-II Trial of Cetuximab, Capecitabine, Oxaliplatin, and Radiotherapy as Preoperative Treatment in Rectal Cancer
-
DOI 10.1016/j.ijrobp.2007.07.2356, PII S0360301607037790
-
Rodel C, Arnold D, Hipp M, et al. Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancer. Int J Radiat Oncol Biol Phys 2008; 70: 1081-6. (Pubitemid 351296110)
-
(2008)
International Journal of Radiation Oncology Biology Physics
, vol.70
, Issue.4
, pp. 1081-1086
-
-
Rodel, C.1
Arnold, D.2
Hipp, M.3
Liersch, T.4
Dellas, K.5
Iesalnieks, I.6
Hermann, R.M.7
Lordick, F.8
Hinke, A.9
Hohenberger, W.10
Sauer, R.11
-
32
-
-
25844507873
-
Can the histopathological assessment of the circumferential margin following pre-operative pelvic chemo-radiotherapy for T3/4 rectal cancer predict for three year disease free survival?
-
Mawdsley S, Glynne-Jones R, Grainger J, et al. Can the histopathological assessment of the circumferential margin following pre-operative pelvic chemo-radiotherapy for T3/4 rectal cancer predict for three year disease free survival? Int J Radiation Oncol Biol Phys 2005; 63: 745-52.
-
(2005)
Int J Radiation Oncol Biol Phys
, vol.63
, pp. 745-752
-
-
Mawdsley, S.1
Glynne-Jones, R.2
Grainger, J.3
-
33
-
-
27644493797
-
A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: A Colorectal Clinical Oncology Group (CCOG) study
-
DOI 10.1038/sj.bjc.6602818, PII 6602818
-
Sebag-Montefiore D, Glynne-Jones R, Falk S, et al. A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group (CCOG) study. Br J Cancer 2005; 93 (9): 993-8. (Pubitemid 41548392)
-
(2005)
British Journal of Cancer
, vol.93
, Issue.9
, pp. 993-998
-
-
Sebag-Montefiore, D.1
Glynne-Jones, R.2
Falk, S.3
Meadows, H.M.4
Maughan, T.5
-
34
-
-
24944499364
-
Enhanced tumoricidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: Preliminary results of EORTC 22921
-
Bosset JF, Calais G,Mineur L, et al. Enhanced tumoricidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results of EORTC 22921. J Clin Oncol 2005; 23: 5620-7.
-
(2005)
J Clin Oncol
, vol.23
, pp. 5620-7
-
-
Bosset, J.F.1
Calais, G.2
Mineur, L.3
-
35
-
-
65649154616
-
Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer: A systematic review and meta-analysis
-
Ceelen W, Fierens K, Van Nieuwenhove Y, et al. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer: a systematic review and meta-analysis. Int J Cancer 2009; 124 (12): 2966-72.
-
(2009)
Int J Cancer
, vol.124
, Issue.12
, pp. 2966-2972
-
-
Ceelen, W.1
Fierens, K.2
Van Nieuwenhove, Y.3
-
36
-
-
0014691062
-
Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer
-
Moertel CG, Childs Jr DS, Reitemeier RJ, et al. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 1996; II: 865-7.
-
(1996)
Lancet
, vol.2
, pp. 865-7
-
-
Moertel, C.G.1
Childs Jr., D.S.2
Reitemeier, R.J.3
-
37
-
-
34250210799
-
Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: Results from NSABP C-07
-
DOI 10.1200/JCO.2006.08.2974
-
Kuebler JP, Wieand HS, O'Connell MJ, et al. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07. J Clin Oncol 2007; 25 (16): 2198-204. (Pubitemid 46954643)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.16
, pp. 2198-2204
-
-
Kuebler, J.P.1
Wieand, H.S.2
O'Connell, M.J.3
Smith, R.E.4
Colangelo, L.H.5
Yothers, G.6
Petrelli, N.J.7
Findlay, M.P.8
Seay, T.E.9
Atkins, J.N.10
Zapas, J.L.11
Goodwin, J.W.12
Fehrenbacher, L.13
Ramanathan, R.K.14
Conley, B.A.15
Flynn, P.J.16
Soori, G.17
Colman, L.K.18
Levine, E.A.19
Lanier, K.S.20
Wolmark, N.21
more..
-
38
-
-
67650315187
-
Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial
-
André T, Boni C, Navarro M, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 2009; 27 (19): 3109-16.
-
(2009)
J Clin Oncol
, vol.27
, Issue.19
, pp. 3109-3116
-
-
André, T.1
Boni, C.2
Navarro, M.3
-
39
-
-
33644846430
-
Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation therapy oncology group trial 0012
-
DOI 10.1200/JCO.2005.03.6095
-
Mohiuddin M, Winter K, Mitchell E, et al. Randomised phase II study of neoadjuvant combined modality chemoradiation in distal rectal cancer. Radiation Oncology Group Trials 0012. J Clin Oncol 2006; 24: 650-5. (Pubitemid 46630429)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.4
, pp. 650-655
-
-
Mohiuddin, M.1
Winter, K.2
Mitchell, E.3
Hanna, N.4
Yuen, A.5
Nichols, C.6
Shane, R.7
Hayostek, C.8
Willett, C.9
-
40
-
-
69549151596
-
Preoperative (FU)- based chemoradiation with and without weekly oxaliplatin in locally advanced rectal cancer; Pathologic response analysis of the Studio Terapia Adjuvante Retto (STAR)-01 randomized phase III trial [abstract no. CRA 4008]
-
(part II of II): 804s
-
Aschele C, Pinto C, Rosati G, et al. Preoperative (FU)- based chemoradiation with and without weekly oxaliplatin in locally advanced rectal cancer; pathologic response analysis of the Studio Terapia Adjuvante Retto (STAR)-01 randomized phase III trial [abstract no. CRA 4008]. J Clin Oncol 2009; 27: 18S (part II of II): 804s.
-
(2009)
J Clin Oncol
, vol.27
-
-
Aschele, C.1
Pinto, C.2
Rosati, G.3
-
41
-
-
77950495945
-
Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: Results of the phase III trial ACCORD 12/0405-Prodige 2
-
Gérard JP, Azria D, Gourgou-Bourgade S, et al. Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol 2010; 28 (10): 1638-44.
-
(2010)
J Clin Oncol
, vol.28
, Issue.10
, pp. 1638-1644
-
-
Gérard, J.P.1
Azria, D.2
Gourgou-Bourgade, S.3
-
42
-
-
2542561964
-
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
-
DOI 10.1056/NEJMoa032691
-
Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350: 2335-42. (Pubitemid 38702844)
-
(2004)
New England Journal of Medicine
, vol.350
, Issue.23
, pp. 2335-2342
-
-
Hurwitz, H.1
Fehrenbacher, L.2
Novotny, W.3
Cartwright, T.4
Hainsworth, J.5
Heim, W.6
Berlin, J.7
Baron, A.8
Griffing, S.9
Holmgren, E.10
Ferrara, N.11
Fyfe, G.12
Rogers, B.13
Ross, R.14
Kabbinavar, F.15
-
43
-
-
73249130298
-
Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: The CELIM randomised phase 2 trial
-
Folprecht G, Gruenberger T, Bechstein WO, et al. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol 2010; 11 (1): 38-47.
-
(2010)
Lancet Oncol
, vol.11
, Issue.1
, pp. 38-47
-
-
Folprecht, G.1
Gruenberger, T.2
Bechstein, W.O.3
-
44
-
-
63849088630
-
Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer
-
Van Cutsem E, Kö hne CH, Hitre E, et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med 2009; 360 (14): 1408-17.
-
(2009)
N Engl J Med
, vol.360
, Issue.14
, pp. 1408-1417
-
-
Van Cutsem, E.1
Köhne, C.H.2
Hitre, E.3
-
45
-
-
59749091477
-
Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer
-
Tol J, Koopman M, Cats A, et al. Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer. N Engl J Med 2009; 360: 563-72.
-
(2009)
N Engl J Med
, vol.360
, pp. 563-572
-
-
Tol, J.1
Koopman, M.2
Cats, A.3
-
47
-
-
27944438828
-
Primary radical external beam radiotherapy of rectal adenocarcinoma: Long term outcome of 271 patients
-
DOI 10.1016/j.radonc.2005.09.001, PII S0167814005003877
-
Wang Y, Cummings B, Catton P, et al. Primary radical external beam radiotherapy of rectal adenocarcinoma: long term outcome of 271 patients. Radiother Oncol 2005; 77 (2): 126-32. (Pubitemid 41682376)
-
(2005)
Radiotherapy and Oncology
, vol.77
, Issue.2
, pp. 126-132
-
-
Wang, Y.1
Cummings, B.2
Catton, P.3
Dawson, L.4
Kim, J.5
Ringash, J.6
Wong, R.7
Yi, Q.-L.8
Brierley, J.9
-
48
-
-
0037445116
-
Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: The Lyon R0-04 phase II trial
-
DOI 10.1200/JCO.2003.10.045
-
Gerard JP, Chapet O, Nemoz C, et al. Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial. J Clin Oncol 2003; 21: 1119-24. (Pubitemid 46594142)
-
(2003)
Journal of Clinical Oncology
, vol.21
, Issue.6
, pp. 1119-1124
-
-
Gerard, J.-P.1
Chapet, O.2
Nemoz, C.3
Romestaing, P.4
Mornex, F.5
Coquard, R.6
Barbet, N.7
Atlan, D.8
Adeleine, P.9
Freyer, G.10
-
49
-
-
0031978182
-
Preoperative radiation affect functional results after surgery for rectal cancer: Results from a randomised study
-
Dahlberg M, Glimerlius B, Graf W, et al. Preoperative radiation affect functional results after surgery for rectal cancer: results from a randomised study. Dis Colon Rectum 1998; 41: 543-9.
-
(1998)
Dis Colon Rectum
, vol.41
, pp. 543-9
-
-
Dahlberg, M.1
Glimerlius, B.2
Graf, W.3
-
50
-
-
0036534143
-
Adjuvant therapy in rectal cancer: Analysis of stage, sex, and local control - Final report of Intergroup 0114
-
DOI 10.1200/JCO.2002.07.132
-
Tepper JE, O'Connell M, Niedzwiecki D, et al. Adjuvant therapy in rectal cancer: analysis of stage, sex and local control: final report of intergroup 0114. J Clin Oncol 2002; 20: 1744-50. (Pubitemid 34273262)
-
(2002)
Journal of Clinical Oncology
, vol.20
, Issue.7
, pp. 1744-1750
-
-
Tepper, J.E.1
O'Connell, M.2
Niedzwiecki, D.3
Hollis, D.R.4
Benson III, A.B.5
Cummings, B.6
Gunderson, L.L.7
Macdonald, J.S.8
Martenson, J.A.9
Mayer, R.J.10
-
51
-
-
0023000608
-
A prospective study of treatment techniques to minimize the volume of pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation
-
Gallagher MJ, Brereton HD, Rostock RA. A prospective study of treatment techniques to minimise the volume of pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation. Int J Radiat Oncol Biol Phys 1986; 12: 1565-73. (Pubitemid 17175240)
-
(1986)
International Journal of Radiation Oncology Biology Physics
, vol.12
, Issue.9
, pp. 1565-1573
-
-
Gallagher, M.J.1
Brereton, H.D.2
Rostock, R.A.3
-
52
-
-
20144362086
-
Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: Report of a multicenter randomized trial
-
DOI 10.1200/JCO.2005.05.256
-
Marijnen CA, van de Velde CJ, Putter H, et al. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 2005; 23 (9): 1847-58. (Pubitemid 46211362)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.9
, pp. 1847-1858
-
-
Marijnen, C.A.M.1
Van De Velde, C.J.H.2
Putter, H.3
Van Den Brink, M.4
Maas, C.P.5
Martijn, H.6
Rutten, H.J.7
Wiggers, T.8
Kranenbarg, E.K.9
Leer, J.-W.H.10
Stiggelbout, A.M.11
-
53
-
-
33644985510
-
Long-term effect of preoperative radiation therapy on anorectal function
-
Pollack J, Holm T, Cedermark B, et al. Long-term effect of preoperative radiation therapy on anorectal function. Dis Colon Rectum 2006; 49 (3): 345-52.
-
(2006)
Dis Colon Rectum
, vol.49
, Issue.3
, pp. 345-352
-
-
Pollack, J.1
Holm, T.2
Cedermark, B.3
-
54
-
-
24944581750
-
Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: Increased bowel dysfunction in irradiated patients
-
Dutch Colorectal Cancer Group study
-
Peeters K, van de Velde C, Leer J, et al. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients. Dutch Colorectal Cancer Group study. J Clin Oncol 2005; 23: 6199-206.
-
(2005)
J Clin Oncol
, vol.23
, pp. 6199-6206
-
-
Peeters, K.1
Van De Velde, C.2
Leer, J.3
-
55
-
-
35348873658
-
Risk factors for faecal incontinence after rectal cancer treatment
-
DOI 10.1002/bjs.5819
-
Lange MM, den DulkM, Bossema ER, et al., Cooperative Clinical Investigators of the Dutch Total Mesorectal Excision Trial. Risk factors for faecal incontinence after rectal cancer treatment. Br J Surg 2007; 94 (10): 1278-84. (Pubitemid 47584779)
-
(2007)
British Journal of Surgery
, vol.94
, Issue.10
, pp. 1278-1284
-
-
Lange, M.M.1
Den Dulk, M.2
Bossema, E.R.3
Maas, C.P.4
Peeters, K.C.M.J.5
Rutten, H.J.6
Klein Kranenbarg, E.7
Marijnen, C.A.M.8
Van De Velde, C.J.H.9
-
56
-
-
0030069492
-
Acute lumbosacral plexopathy during and after preoperative radiotherapy of rectal adenocarcinoma
-
DOI 10.1016/0167-8140(95)01665-1
-
Frykholm GJ, Sintorn K, Montelius A, et al. Acute lumbosacral plexopathy during and after preoperative radiotherapy of rectal adenocarcinoma. Radiother Oncol 1996; 38 (2): 121-30. (Pubitemid 26061033)
-
(1996)
Radiotherapy and Oncology
, vol.38
, Issue.2
, pp. 121-130
-
-
Frykholm, G.J.1
Sintorn, K.2
Montelius, A.3
Jung, B.4
Pahlman, L.5
Glimelius, B.6
-
57
-
-
33644845287
-
Adverse effects of preoperative radiation therapy for rectal cancer: Longterm follow-up of the Swedish rectal Cancer Trial
-
Birgisson H, Pahlman L, Glimelius B. Adverse effects of preoperative radiation therapy for rectal cancer: longterm follow-up of the Swedish rectal Cancer Trial. J Clin Oncol 2006; 23: 8697-705.
-
(2006)
J Clin Oncol
, vol.23
, pp. 8697-8705
-
-
Birgisson, H.1
Pahlman, L.2
Glimelius, B.3
-
58
-
-
24944491781
-
Occurrence of second cancers in patients treated with radiotherapy for rectal cancer
-
Birgisson H, Pahlman L, Gunnarsson U, et al. Occurrence of second cancers in patients treated with radiotherapy for rectal cancer. J Clin Oncol 2005; 23: 6126-31.
-
(2005)
J Clin Oncol
, vol.23
, pp. 6126-6131
-
-
Birgisson, H.1
Pahlman, L.2
Gunnarsson, U.3
-
59
-
-
28144443357
-
Risk of pelvic fractures in older women following pelvic irradiation
-
DOI 10.1001/jama.294.20.2587
-
Baxter NN, Habermann EB, Tepper JE, et al. Risk of pelvic fractures in older women following pelvic irradiation. JAMA 2005; 294 (20): 2587-93. (Pubitemid 41697248)
-
(2005)
Journal of the American Medical Association
, vol.294
, Issue.20
, pp. 2587-2593
-
-
Baxter, N.N.1
Habermann, E.B.2
Tepper, J.E.3
Durham, S.B.4
Virnig, B.A.5
-
60
-
-
67349237912
-
Sacral insufficiency fractures after preoperative chemoradiation for rectal cancer: Incidence, risk factors, and clinical course
-
Herman MP, Kopetz S, Bhosale PR, et al. Sacral insufficiency fractures after preoperative chemoradiation for rectal cancer: incidence, risk factors, and clinical course. Int J Radiat Oncol Biol Phys 2009; 74 (3): 818-23.
-
(2009)
Int J Radiat Oncol Biol Phys
, vol.74
, Issue.3
, pp. 818-823
-
-
Herman, M.P.1
Kopetz, S.2
Bhosale, P.R.3
-
61
-
-
0032127244
-
Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5 fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue
-
DOI 10.1016/S0959-8049(98)00058-6, PII S0959804998000586
-
Miwa M, Ura M, Nishida M, et al. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumors by enzymes concentrated in human liver and cancer tissue. Eur J Cancer 1998; 34: 1274-81. (Pubitemid 28342121)
-
(1998)
European Journal of Cancer
, vol.34
, Issue.8
, pp. 1274-1281
-
-
Miwa, M.1
Ura, M.2
Nishida, M.3
Sawada, N.4
Ishikawa, T.5
Mori, K.6
Shimma, N.7
Umeda, I.8
Ishitsuka, H.9
-
62
-
-
0032520168
-
Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts
-
Ishikawa T, Sekiguchi F, Fukase Y, et al. Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumours in human tumour xenografts. Cancer Res 1998; 58: 685-90. (Pubitemid 28099478)
-
(1998)
Cancer Research
, vol.58
, Issue.4
, pp. 685-690
-
-
Ishikawa, T.1
Sekiguchi, F.2
Fukase, Y.3
Sawada, N.4
Ishitsuka, H.5
-
63
-
-
0034016415
-
Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients
-
Schü ller J, Cassidy J, Dumont E, et al. Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients. Cancer Chemother Pharmacol 2000; 45: 291-7. (Pubitemid 30151522)
-
(2000)
Cancer Chemotherapy and Pharmacology
, vol.45
, Issue.4
, pp. 291-297
-
-
Schuller, J.1
Cassidy, J.2
Dumont, E.3
Roos, B.4
Weidekamm, E.5
Reigner, B.6
Durston, S.7
Banken, L.8
Utoh, M.9
Mori, K.10
-
64
-
-
37349040121
-
Capecitabine vs continuous infusion 5-FU in neoadjuvant treatment of rectal cancer. A retrospective review
-
DOI 10.1007/s00384-007-0382-z
-
Saif MW, Hashmi S, Zelterman D, et al. Capecitabine vs continuous infusion 5-FU in neoadjuvant treatment of rectal cancer: a retrospective review. Int J Colorectal Dis 2008; 23 (2): 139-45. (Pubitemid 350302509)
-
(2008)
International Journal of Colorectal Disease
, vol.23
, Issue.2
, pp. 139-145
-
-
Saif, M.W.1
Hashmi, S.2
Zelterman, D.3
Almhanna, K.4
Kim, R.5
-
65
-
-
37049017365
-
Preoperative chemoradiotherapy for rectal cancer: Randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin
-
De la Torre A, Garcia-Berical MI, Arrias F, et al. Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin. Int J Radiation Oncol Biol Phys 2008; 17: 102-10.
-
(2008)
Int J Radiation Oncol Biol Phys
, vol.17
, pp. 102-110
-
-
De La Torre, A.1
Garcia-Berical, M.I.2
Arrias, F.3
-
66
-
-
77952297822
-
Capecitabine (Cape) versus 5-fluorouracil (5-FU)-based (neo-)adjuvant chemoradiotherapy (CRT) for locally advanced rectal cancer (LARC): Safety results of a randomized, phase III trial [abstract]
-
(May 20 Suppl. 4014)
-
Hofheinz R, Wenz F, Post S, et al. Capecitabine (Cape) versus 5-fluorouracil (5-FU)-based (neo-)adjuvant chemoradiotherapy (CRT) for locally advanced rectal cancer (LARC): Safety results of a randomized, phase III trial [abstract]. J Clin Oncol 2009; 27: 15S (May 20 Suppl.): 4014.
-
(2009)
J Clin Oncol
, vol.27
-
-
Hofheinz, R.1
Wenz, F.2
Post, S.3
-
67
-
-
77954719685
-
Radiation, chemotherapy and biological therapy in the curative treatment of locally advanced rectal cancer
-
Gollins S. Radiation, chemotherapy and biological therapy in the curative treatment of locally advanced rectal cancer. Colorectal Dis 2010; 12 Suppl. 2: 2-24.
-
(2010)
Colorectal Dis
, vol.12
, Issue.SUPPL. 2
, pp. 2-24
-
-
Gollins, S.1
-
68
-
-
57849167225
-
RTOG 0247: A randomized phase II study of neoadjuvant capecitabine and irinotecan versus capecitabine and oxaliplatin with concurrent radiation therapy for locally advanced rectal cancer [ abstract no. 4021]
-
May 20
-
Wong SJ, Winter K, Meropol NJ, et al. RTOG 0247: A randomized phase II study of neoadjuvant capecitabine and irinotecan versus capecitabine and oxaliplatin with concurrent radiation therapy for locally advanced rectal cancer [abstract no. 4021]. J Clin Oncol 2008 May 20; 26 Suppl.: 183s.
-
(2008)
J Clin Oncol
, vol.26
, Issue.SUPPL.
-
-
Wong, S.J.1
Winter, K.2
Meropol, N.J.3
-
69
-
-
0030990974
-
Pathological features of rectal cancer after preoperative radiochemotherapy
-
DOI 10.1007/s003840050072
-
Dworak O, Keilholz L, Hoffman A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997; 12: 19-23. (Pubitemid 27138353)
-
(1997)
International Journal of Colorectal Disease
, vol.12
, Issue.1
, pp. 19-23
-
-
Dworak, O.1
Keilholz, L.2
Hoffmann, A.3
-
70
-
-
29844435015
-
A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer
-
DOI 10.1093/annonc/mdj031
-
Glynne-Jones R, Sebag-Montefiore D, Maughan TS, et al. A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer. Ann Oncol 2006; 17 (1): 50-6. (Pubitemid 43033839)
-
(2006)
Annals of Oncology
, vol.17
, Issue.1
, pp. 50-56
-
-
Glynne-Jones, R.1
Sebag-Montefiore, D.2
Maughan, T.S.3
Falk, S.J.4
McDonald, A.C.5
-
71
-
-
38649121717
-
Tumor response to neoadjuvant chemoradiation in rectal canceri predictor for surgical morbidity?
-
Horisberger K, Hofheinz RD, Palma P, et al. Tumor response to neoadjuvant chemoradiation in rectal cancer: predictor for surgical morbidity? Int J Colorectal Dis 2008; 23 (3): 257-64.
-
(2008)
Int J Colorectal Dis
, vol.23
, Issue.3
, pp. 257-264
-
-
Horisberger, K.1
Hofheinz, R.D.2
Palma, P.3
-
72
-
-
67349087929
-
Postoperative morbidity following chemoradiation for locally advanced low rectal cancer
-
Stelzmueller I, Zitt M, Aigner F, et al. Postoperative morbidity following chemoradiation for locally advanced low rectal cancer. J Gastrointest Surg 2009; 13: 657-67.
-
(2009)
J Gastrointest Surg
, vol.13
, pp. 657-667
-
-
Stelzmueller, I.1
Zitt, M.2
Aigner, F.3
-
73
-
-
78149250536
-
Randomized phase II trial of panitumumab with infusional fluorouracil, leucovorin and oxaliplatin (FOLFOX 4) versus FOLFOX4 alone as first line treatment in patients with previously untreated metastatic colorectal cancer
-
The PRIME study
-
Douillard JY, Siena S, Cassidy J, et al. Randomized phase II trial of panitumumab with infusional fluorouracil, leucovorin and oxaliplatin (FOLFOX 4) versus FOLFOX4 alone as first line treatment in patients with previously untreated metastatic colorectal cancer. The PRIME study. J Clin Oncol 2010; 28 (31): 4697-705.
-
(2010)
J Clin Oncol
, vol.28
, Issue.31
, pp. 4697-4705
-
-
Douillard, J.Y.1
Siena, S.2
Cassidy, J.3
-
74
-
-
79551521053
-
Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: Results of NSABP protocol C-08
-
Allegra CJ, Yothers G, O'Connell MJ, et al. Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08. J Clin Oncol 2011; 29 (1): 11-6.
-
(2011)
J Clin Oncol
, vol.29
, Issue.1
, pp. 11-16
-
-
Allegra, C.J.1
Yothers, G.2
O'Connell, M.J.3
-
75
-
-
77956689048
-
Adjuvant mFOLFOX6 plus or minus cetuximab (Cmab) in patients (pts) with KRAS mutant (m) resected stage III colon cancer (CC): NCCTG Intergroup Phase III Trial N0147 [ abstract no. 3508]
-
Goldberg RM, Sargent DJ, Thibodeau SN, et al. Adjuvant mFOLFOX6 plus or minus cetuximab (Cmab) in patients (pts) with KRAS mutant (m) resected stage III colon cancer (CC): NCCTG Intergroup Phase III Trial N0147 [abstract no. 3508]. J Clin Oncol 2010; 28 Suppl.: 262s.
-
(2010)
J Clin Oncol
, vol.28
, Issue.SUPPL.
-
-
Goldberg, R.M.1
Sargent, D.J.2
Thibodeau, S.N.3
-
76
-
-
73249143536
-
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial and relation between cetuximab-induced rash and survival
-
Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol 2010; 11 (1): 21-8.
-
(2010)
Lancet Oncol
, vol.11
, Issue.1
, pp. 21-28
-
-
Bonner, J.A.1
Harari, P.M.2
Giralt, J.3
-
77
-
-
33750357154
-
Integration of EGFR inhibitors with radiochemotherapy
-
DOI 10.1038/nrc1953, PII NRC1953
-
Nyati MK, Morgan MA, Feng FY, et al. Integration of EGFR inhibitors with radiochemotherapy. Nat Rev Cancer 2006; 6: 876-85. (Pubitemid 44629899)
-
(2006)
Nature Reviews Cancer
, vol.6
, Issue.11
, pp. 876-885
-
-
Nyati, M.K.1
Morgan, M.A.2
Feng, F.Y.3
Lawrence, T.S.4
-
78
-
-
80053591096
-
Preoperative chemoradiation with cetuximab, irinotecan, and capecitabine in patients with locally advanced resectable rectal cancer: A multicenter phase II study
-
Epub 2010 Sep 30
-
Kim SY, Hong YS, Kim DY, et al. Preoperative chemoradiation with cetuximab, irinotecan, and capecitabine in patients with locally advanced resectable rectal cancer: a multicenter phase II study. Int J Radiat Oncol Biol Phys. Epub 2010 Sep 30.
-
Int J Radiat Oncol Biol Phys.
-
-
Kim, S.Y.1
Hong, Y.S.2
Kim, D.Y.3
-
79
-
-
76449085548
-
A phase II study of cetuximab, capecitabine and radiotherapy in neoadjuvant treatment of patients with locally advanced resectable rectal cancer
-
Velenik V, Ocvirk J, Oblak I, et al. A phase II study of cetuximab, capecitabine and radiotherapy in neoadjuvant treatment of patients with locally advanced resectable rectal cancer. Eur J Surg Oncol 2010; 36 (3): 244-50.
-
(2010)
Eur J Surg Oncol
, vol.36
, Issue.3
, pp. 244-250
-
-
Velenik, V.1
Ocvirk, J.2
Oblak, I.3
-
80
-
-
77951261079
-
Neoadjuvant chemoradiation therapy with capecitabine plus cetuximab and external beam radiotherapy in locally advanced rectal cancer (LARC) ABCSG trial R03 [abstract 4109]
-
II
-
Eisterer WM, De Vries A, Oefner D, et al. Neoadjuvant chemoradiation therapy with capecitabine plus cetuximab and external beam radiotherapy in locally advanced rectal cancer (LARC) ABCSG trial R03 [abstract 4109]. J Clin Oncol 2009; 27 (15S pt I of II): 195s.
-
(2009)
J Clin Oncol
, vol.27
, Issue.15 PART 1
-
-
Eisterer, W.M.1
De Vries, A.2
Oefner, D.3
-
81
-
-
67749097665
-
Cetuximab in combination with capecitabine, irinotecan, and radiotherapy for patients with locally advanced rectal cancer: Results of a phase II MARGIT trial
-
MARGIT (Mannheimer Arbeitsgruppe fü r Gastrointestinale Tumoren)
-
Horisberger K, Treschl A, Mai S, et al. MARGIT (Mannheimer Arbeitsgruppe fü r Gastrointestinale Tumoren). Cetuximab in combination with capecitabine, irinotecan, and radiotherapy for patients with locally advanced rectal cancer: results of a phase II MARGIT trial. Int J Radiation Oncol Biol Phys 2009; 74 (5): 1487-93.
-
(2009)
Int J Radiation Oncol Biol Phys
, vol.74
, Issue.5
, pp. 1487-1493
-
-
Horisberger, K.1
Treschl, A.2
Mai, S.3
-
82
-
-
57849155450
-
Phase i trial of preoperative cetuximab in combination with oxaliplatin, capecitabine, and radiation therapy for locally advanced rectal cancer [abstract]
-
May 20
-
Cabebe EC, Kuo T, Koong A, et al. Phase I trial of preoperative cetuximab in combination with oxaliplatin, capecitabine, and radiation therapy for locally advanced rectal cancer [abstract]. J Clin Oncol 2008; 26 (May 20 Suppl.): 15019.
-
(2008)
J Clin Oncol
, vol.26
, Issue.SUPPL.
, pp. 15019
-
-
Cabebe, E.C.1
Kuo, T.2
Koong, A.3
-
83
-
-
58149345226
-
Neoadjuvant treatment with single agent cetuximab followed by 5-FU, cetuximab and pelvic radiotherapy: A phase II study in locally advanced rectal cancer
-
Bertolini F, Chiara S, Bengala C, et al. Neoadjuvant treatment with single agent cetuximab followed by 5-FU, cetuximab and pelvic radiotherapy: a phase II study in locally advanced rectal cancer. Int J Radiation Oncol Biol Phys 2009; 73 (2): 466-72.
-
(2009)
Int J Radiation Oncol Biol Phys
, vol.73
, Issue.2
, pp. 466-472
-
-
Bertolini, F.1
Chiara, S.2
Bengala, C.3
-
84
-
-
38849166120
-
Phase II study of preoperative chemoradiation (CRT) with cetuximab, irinotecan and capecitabine in patients with locally advanced resectable rectal cancer [abstract]
-
Hong YS, Kim DY, Lee KS, et al. Phase II study of preoperative chemoradiation (CRT) with cetuximab, irinotecan and capecitabine in patients with locally advanced resectable rectal cancer [abstract]. J Clin Oncol 2007; 25 (18S): 4045.
-
(2007)
J Clin Oncol
, vol.25
, Issue.18 S
, pp. 4045
-
-
Hong, Y.S.1
Kim, D.Y.2
Lee, K.S.3
-
85
-
-
34047179551
-
Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer
-
DOI 10.1093/annonc/mdl460
-
Machiels JP, Sempoux C, Scalliet P, et al. Phase I/II study of preoperative cetuximab, capecitabine and external beam radiotherapy in patients with rectal cancer. Ann Oncol 2007; 18: 738-44. (Pubitemid 46523279)
-
(2007)
Annals of Oncology
, vol.18
, Issue.4
, pp. 738-744
-
-
Machiels, J.-P.1
Sempoux, C.2
Scalliet, P.3
Coche, J.-C.4
Humblet, Y.5
Van Cutsem, E.6
Kerger, J.7
Canon, J.-L.8
Peeters, M.9
Aydin, S.10
Laurent, S.11
Kartheuser, A.12
Coster, B.13
Roels, S.14
Daisne, J.-F.15
Honhon, B.16
Duck, L.17
Kirkove, C.18
Bonny, M.-A.19
Haustermans, K.20
more..
-
86
-
-
33750904963
-
Phase i trial of preoperative cetuximab with concurrent continuous infusion 5-fluorouracil and pelvic radiation in patients with local-regionally advanced rectal cancer [abstract]
-
Chung KY, Minsky B, Schrag D, et al. Phase I trial of preoperative cetuximab with concurrent continuous infusion 5-fluorouracil and pelvic radiation in patients with local-regionally advanced rectal cancer [abstract]. J Clin Oncol 2006; 24: 18S: 3560.
-
(2006)
J Clin Oncol
, vol.24
, Issue.18 S
, pp. 3560
-
-
Chung, K.Y.1
Minsky, B.2
Schrag, D.3
-
87
-
-
33751169352
-
Phase i trial of cetuximab in combination with capecitabine, weekly irinotecan and radiotherapy as neoadjuvant therapy for rectal cancer
-
Hoffheinz R-D, Horisberger K, Woernle C, et al. Phase I trial of cetuximab in combination with capecitabine, weekly irinotecan and radiotherapy as neoadjuvant therapy for rectal cancer. Int J Radiat Oncol Biol Phys 2006; 66: 1384-90.
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.66
, pp. 1384-1390
-
-
Hoffheinz, R.-D.1
Horisberger, K.2
Woernle, C.3
-
88
-
-
79959349114
-
EXPERTC: A randomized phase II European multicenter trial of neoadjuvant chemotherapy (capecitabine/oxaliplatin) and chemoradiation (CRT) with or without cetuximab followed by total mesorectal excision (TME) in patients with MRI-defined high-risk rectal cancer [abstract no. 360]
-
Dewdney A, Cunningham D, Tabernero J, et al. EXPERTC: a randomized phase II European multicenter trial of neoadjuvant chemotherapy (capecitabine/ oxaliplatin) and chemoradiation (CRT) with or without cetuximab followed by total mesorectal excision (TME) in patients with MRI-defined high-risk rectal cancer [abstract no. 360]. J Clin Oncol 2011; 29 Suppl. 4: 360.
-
(2011)
J Clin Oncol
, vol.29
, Issue.SUPPL. 4
, pp. 360
-
-
Dewdney, A.1
Cunningham, D.2
Tabernero, J.3
-
89
-
-
74049108229
-
Molecular response to cetuximab and efficacy of preoperative cetuximab-based chemoradiation in rectal cancer
-
Debucquoy A, Haustermanns K, Daemen A, et al. Molecular response to cetuximab and efficacy of preoperative cetuximab-based chemoradiation in rectal cancer. J Clin Oncol 2009; 27 (17): 2751-7.
-
(2009)
J Clin Oncol
, vol.27
, Issue.17
, pp. 2751-7
-
-
Debucquoy, A.1
Haustermanns, K.2
Daemen, A.3
-
90
-
-
32144433159
-
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
-
DOI 10.1056/NEJMoa053422
-
Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous cell carcinoma of the head and neck. N Engl J Med 2006; 354 (6): 567-78. (Pubitemid 43209104)
-
(2006)
New England Journal of Medicine
, vol.354
, Issue.6
, pp. 567-578
-
-
Bonner, J.A.1
Harari, P.M.2
Giralt, J.3
Azarnia, N.4
Shin, D.M.5
Cohen, R.B.6
Jones, C.U.7
Sur, R.8
Raben, D.9
Jassem, J.10
Ove, R.11
Kies, M.S.12
Baselga, J.13
Youssoufian, H.14
Amellal, N.15
Rowinsky, E.K.16
Ang, K.K.17
-
91
-
-
70349641356
-
Cetuximab plus cisplatin-5-fluorouracil versus cisplatin-5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: A randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie
-
Lorenzen S, Schuster T, Porschen R, et al. Cetuximab plus cisplatin-5-fluorouracil versus cisplatin-5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie. Ann Oncol 2009; 20 (10): 1667-73.
-
(2009)
Ann Oncol
, vol.20
, Issue.10
, pp. 1667-1673
-
-
Lorenzen, S.1
Schuster, T.2
Porschen, R.3
-
92
-
-
79953236184
-
AVANT: Results from a randomized, three-arm multinational phase III study to investigate bevacizumab with either XELOX or FOLFOX4 versus FOLFOX4 alone as adjuvant treatment for colon cancer [ abstract no. 362]
-
de Gramont A, Van CutsemE, Tabernero J, et al. AVANT: results from a randomized, three-arm multinational phase III study to investigate bevacizumab with either XELOX or FOLFOX4 versus FOLFOX4 alone as adjuvant treatment for colon cancer [abstract no. 362]. J Clin Oncol 2011; 29 Suppl. 4: 362.
-
(2011)
J Clin Oncol
, vol.29
, Issue.SUPPL. 4
, pp. 362
-
-
De Gramont, A.1
Van Cutsem, E.2
Tabernero, J.3
-
93
-
-
11144354392
-
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
-
DOI 10.1038/nm988
-
Willett C, Boucher Y, di Tomaso E, et al. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. NatMed 2004; 10: 145-7. (Pubitemid 38524883)
-
(2004)
Nature Medicine
, vol.10
, Issue.2
, pp. 145-147
-
-
Willett, C.G.1
Boucher, Y.2
Di Tomaso, E.3
Duda, D.G.4
Munn, L.L.5
Tong, R.T.6
Chung, D.C.7
Sahani, D.V.8
Kalva, S.P.9
Kozin, S.V.10
Mino, M.11
Cohen, K.S.12
Scadden, D.T.13
Hartford, A.C.14
Fischman, A.J.15
Clark, J.W.16
Ryan, D.P.17
Zhu, A.X.18
Blaszkowsky, L.S.19
Chen, H.X.20
Shellito, P.C.21
Lauwers, G.Y.22
Jain, R.K.23
more..
-
94
-
-
67649921334
-
Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: A multidisciplinary phase II study
-
Willett CG, Duda DG, di Tomaso E, et al. Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study. J Clin Oncol 2009; 27 (18): 3020-6.
-
(2009)
J Clin Oncol
, vol.27
, Issue.18
, pp. 3020-6
-
-
Willett, C.G.1
Duda, D.G.2
Di Tomaso, E.3
-
95
-
-
34247848005
-
Bevacizumab, oxaliplatin, and capecitabine with radiation therapy in rectal cancer: Phase I trial results
-
DOI 10.1016/j.ijrobp.2007.02.001, PII S0360301607002519
-
Czito B, Bendell J, Willett C, et al. Bevacizamab, oxaliplatin and capecitabine with radiation therapy and rectal cancer: phase I trial results. Int J Radiat Oncol Biol Phys 2007; 68: 472-8. (Pubitemid 46694189)
-
(2007)
International Journal of Radiation Oncology Biology Physics
, vol.68
, Issue.2
, pp. 472-478
-
-
Czito, B.G.1
Bendell, J.C.2
Willett, C.G.3
Morse, M.A.4
Blobe, G.C.5
Tyler, D.S.6
Thomas, J.7
Ludwig, K.A.8
Mantyh, C.R.9
Ashton, J.10
Yu, D.11
Hurwitz, H.I.12
-
96
-
-
76049088643
-
Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer
-
Crane CH, Eng C, Feig BW, et al. Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2010; 76 (3): 824-30.
-
(2010)
Int J Radiat Oncol Biol Phys
, vol.76
, Issue.3
, pp. 824-830
-
-
Crane, C.H.1
Eng, C.2
Feig, B.W.3
-
97
-
-
83955163008
-
Neoadjuvant bevacizumab oxaliplatin 5-fluorouracil and radiation for rectal cancer
-
Epub 2010 Oct 13
-
Dipetrillo T, Pricolo V, Lagares-Garcia J, et al. Neoadjuvant bevacizumab, oxaliplatin, 5-fluorouracil, and radiation for rectal cancer. Int J Radiat Oncol Biol Phys. Epub 2010 Oct 13.
-
Int J Radiat Oncol Biol Phys.
-
-
Dipetrillo, T.1
Pricolo, V.2
Lagares-Garcia, J.3
-
98
-
-
84870630439
-
Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally advanced rectal cancer [ abstract no. 516]
-
Martinez Villacampa M, Santos C, Garcia M, et al. Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally advanced rectal cancer [abstract no. 516]. J Clin Oncol 2011; 29 Suppl. 4: 516.
-
(2011)
J Clin Oncol
, vol.29
, Issue.SUPPL. 4
, pp. 516
-
-
Martinez Villacampa, M.1
Santos, C.2
Garcia, M.3
-
99
-
-
79251620917
-
Technical feasibility of laparoscopic total mesorectal excision for patients with low rectal cancer after concurrent radiation and chemotherapy with bevacizumab plus FOLFOX
-
Liang JT, Lai HS, Cheng KW. Technical feasibility of laparoscopic total mesorectal excision for patients with low rectal cancer after concurrent radiation and chemotherapy with bevacizumab plus FOLFOX. Surg Endosc 2011; 25 (1): 305-8.
-
(2011)
Surg Endosc
, vol.25
, Issue.1
, pp. 305-8
-
-
Liang, J.T.1
Lai, H.S.2
Cheng, K.W.3
-
100
-
-
33750586461
-
Role of neoadjuvant chemotherapy in rectal cancer: Interpretation of the EXPERT study [author reply]
-
Chau I, Brown G, Cunningham D, et al. Role of neoadjuvant chemotherapy in rectal cancer: interpretation of the EXPERT study [author reply]. J Clin Oncol 2006; 24 (28): 4665-6.
-
(2006)
J Clin Oncol
, vol.24
, Issue.28
, pp. 4665-6
-
-
Chau, I.1
Brown, G.2
Cunningham, D.3
-
101
-
-
77649209505
-
Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer
-
Grupo Cancer de Recto 3 study
-
Ferná ndez-Martos C, Pericay C, Aparicio J, et al. Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo Cancer de Recto 3 study. J Clin Oncol 2010; 28 (5): 859-65.
-
(2010)
J Clin Oncol
, vol.28
, Issue.5
, pp. 859-865
-
-
Fernández-Martos, C.1
Pericay, C.2
Aparicio, J.3
-
102
-
-
77349110719
-
Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: A phase 2 trial
-
Chua YJ, Barbachano Y, Cunningham D, et al. Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial. Lancet Oncol 2010; 11 (3): 241-8.
-
(2010)
Lancet Oncol
, vol.11
, Issue.3
, pp. 241-8
-
-
Chua, Y.J.1
Barbachano, Y.2
Cunningham, D.3
-
103
-
-
73949100835
-
Increasing the rates of complete response to neoadjuvant chemoradiotherapy for distal rectal cancer: Results of a prospective study using additional chemotherapy during the resting period
-
Habr-Gama A, Perez RO, Sabbaga J, et al. Increasing the rates of complete response to neoadjuvant chemoradiotherapy for distal rectal cancer: results of a prospective study using additional chemotherapy during the resting period. Dis Colon Rectum 2009; 52 (12): 1927-34.
-
(2009)
Dis Colon Rectum
, vol.52
, Issue.12
, pp. 1927-1934
-
-
Habr-Gama, A.1
Perez, R.O.2
Sabbaga, J.3
-
104
-
-
77956662920
-
Neoadjuvant FOLFOX-bev, without radiation, for locally advanced rectal cancer [ abstract no. 3511]
-
Schrag MR, Weiser KA, Goodman KA, et al. Neoadjuvant FOLFOX-bev, without radiation, for locally advanced rectal cancer [abstract no. 3511]. J Clin Oncol 2010; 28 (15 Suppl.): 3511.
-
(2010)
J Clin Oncol
, vol.28
, Issue.15 SUPPL.
, pp. 3511
-
-
Schrag, M.R.1
Weiser, K.A.2
Goodman, K.A.3
-
106
-
-
79957978117
-
Complete pathological response in the primary of rectal or colon cancer treated with FOLFOX without radiation [ abstract no. 3649]
-
Cercek A, Weiser MR, Goodman KA, et al., Complete pathological response in the primary of rectal or colon cancer treated with FOLFOX without radiation [abstract no. 3649]. J Clin Oncol 2010; 28 Suppl.: 15s.
-
(2010)
J Clin Oncol
, vol.28
, Issue.SUPPL.
-
-
Cercek, A.1
Weiser, M.R.2
Goodman, K.A.3
-
107
-
-
80054764140
-
Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: A prospective, multicenter, European study that recruited consecutive patients with rectal cancer
-
for the MERCURY study group Epub 2011 Jan 13
-
Taylor FG, Quirke P, Heald RJ, et al., for the MERCURY study group. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study that recruited consecutive patients with rectal cancer. Ann Surg. Epub 2011 Jan 13.
-
Ann Surg.
-
-
Taylor, F.G.1
Quirke, P.2
Heald, R.J.3
-
108
-
-
79959950514
-
Preoperative chemoradiation may not always be needed for patients with T3 and T2N+ rectal cancer
-
Epub 2011 Jan 24
-
Frasson M, Garcia-Granero E, Roda D, et al. Preoperative chemoradiation may not always be needed for patients with T3 and T2N+ rectal cancer. Cancer. Epub 2011 Jan 24.
-
Cancer
-
-
Frasson, M.1
Garcia-Granero, E.2
Roda, D.3
-
109
-
-
33750297634
-
Major abdominal surgery increases plasma levels of vascular endothelial growth factor: Open more so than minimally invasive methods
-
DOI 10.1097/01.sla.0000225272.52313.e2, PII 0000065820061100000025
-
Belizon A, Balik E, Feingold DL. Major abdominal surgery increases plasma levels of vascular endothelial growth factor: open more so than minimally invasive methods. Ann Surg 2006; 244 (5): 792-8. (Pubitemid 44629954)
-
(2006)
Annals of Surgery
, vol.244
, Issue.5
, pp. 792-798
-
-
Belizon, A.1
Balik, E.2
Feingold, D.L.3
Bessler, M.4
Arnell, T.D.5
Forde, K.A.6
Horst, P.K.7
Jain, S.8
Cekic, V.9
Kirman, I.10
Whelan, R.L.11
-
110
-
-
70350399887
-
Future directions in neoadjuvant therapy of rectal cancer: Maximizing pathological complete response rates
-
Mohiuddin M, Mohiuddin MM, Marks J, et al. Future directions in neoadjuvant therapy of rectal cancer: maximizing pathological complete response rates. Cancer Treat Rev 2009; 35 (7): 547-52.
-
(2009)
Cancer Treat Rev
, vol.35
, Issue.7
, pp. 547-552
-
-
Mohiuddin, M.1
Mohiuddin, M.M.2
Marks, J.3
-
111
-
-
33846264909
-
Importance of maintenance therapy in C225-induced enhancement of tumor control by fractionated radiation
-
DOI 10.1016/j.ijrobp.2006.09.044, PII S036030160603224X
-
Milas L, Fang FM, Mason KA, et al. Importance of maintenance therapy in C225-induced enhancement of tumor control by fractionated radiation. Int J Radiat Oncol Biol Phys 2007; 67: 568-72. (Pubitemid 46108328)
-
(2007)
International Journal of Radiation Oncology Biology Physics
, vol.67
, Issue.2
, pp. 568-572
-
-
Milas, L.1
Fang, F.-M.2
Mason, K.A.3
Valdecanas, D.4
Hunter, N.5
Koto, M.6
Ang, K.K.7
-
112
-
-
35148830050
-
Treatment schedule is of importance when gefitinib is combined with irradiation of glioma and endothelial cells in vitro
-
DOI 10.1080/02841860701253045, PII 772831929
-
Andersson U, Johansson D, Benham-Motlagh P, et al. Treatment schedule is of importance when gefitinib is combined with irradiation of glioma and endothelial cells in vitro. Acta Oncol 2007; 46 (7): 951-60. (Pubitemid 47537180)
-
(2007)
Acta Oncologica
, vol.46
, Issue.7
, pp. 951-960
-
-
Andersson, U.1
Johansson, D.2
Behnam-Motlagh, P.3
Johansson, M.4
Malmer, B.5
-
113
-
-
77957769325
-
Cetuximab may inhibit tumor growth and angiogenesis induced by ionising radiation: A preclinical rationale for maintenance treatment after radiotherapy
-
Pueyo G, Mesia R, Figueras A, et al. Cetuximab may inhibit tumor growth and angiogenesis induced by ionising radiation: a preclinical rationale for maintenance treatment after radiotherapy. Oncologist 2010; 15 (9): 976-86.
-
(2010)
Oncologist
, vol.15
, Issue.9
, pp. 976-986
-
-
Pueyo, G.1
Mesia, R.2
Figueras, A.3
-
114
-
-
2542615200
-
Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer
-
DOI 10.1056/NEJMoa032709
-
Andre T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil as adjuvant treatment for colon cancer. N Engl J Med 2004; 23: 2343-51. (Pubitemid 38702845)
-
(2004)
New England Journal of Medicine
, vol.350
, Issue.23
, pp. 2343-2351
-
-
Andre, T.1
Boni, C.2
Mounedji-Boudiaf, L.3
Navarro, M.4
Tabernero, J.5
Hickish, T.6
Topham, C.7
Zaninelli, M.8
Clingan, P.9
Bridgewater, J.10
Tabah-Fisch, I.11
De Gramont, A.12
-
115
-
-
67650290547
-
Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3
-
Van Cutsem E, Labianca R, Bodoky G, et al. Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3. J Clin Oncol 2009; 27 (19): 3117-25.
-
(2009)
J Clin Oncol
, vol.27
, Issue.19
, pp. 3117-3125
-
-
Van Cutsem, E.1
Labianca, R.2
Bodoky, G.3
-
116
-
-
36849064682
-
Adjuvant chemotherapy versus observation in patients with colorectal cancer: A randomised study
-
Quasar Collaborative Group
-
Quasar Collaborative Group, Gray R, Barnwell J, et al. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet 2007; 370 (9604): 2020-9.
-
(2007)
Lancet
, vol.370
, Issue.9604
, pp. 2020-9
-
-
Gray, R.1
Barnwell, J.2
-
117
-
-
35348817933
-
Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: Does anybody benefit from adjuvant fluorouracil-based chemotherapy?
-
European Organisation for Research and Treatment of Cancer Radiation Oncology Group Atrial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group
-
Collette L, Bosset JF, den Dulk M, et al., European Organisation for Research and Treatment of Cancer Radiation Oncology Group. Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? Atrial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group. J Clin Oncol 2007; 25 (28): 4379-86.
-
(2007)
J Clin Oncol
, vol.25
, Issue.28
, pp. 4379-4386
-
-
Collette, L.1
Bosset, J.F.2
Den Dulk, M.3
-
118
-
-
78649467773
-
Final results of randomized trial on adjuvant chemotherapy after preoperative chemoradiation in rectal cancer [abstract]
-
Cionini L, Sainato A, De Paoli A, et al. Final results of randomized trial on adjuvant chemotherapy after preoperative chemoradiation in rectal cancer [abstract]. Radiother Oncol 2010; 96 Suppl. 1: S113-4.
-
(2010)
Radiother Oncol
, vol.96
, Issue.SUPPL. 1
-
-
Cionini, L.1
Sainato, A.2
De Paoli, A.3
-
119
-
-
43049141199
-
Adjuvant chemotherapy for rectal cancer [letter]
-
McConkey C on behalf of the Quasar Investigators author reply 1503
-
Gray R, McConkey C, on behalf of the Quasar Investigators. Adjuvant chemotherapy for rectal cancer [letter]. Lancet 2008; 371 (9623): 1502-3; author reply 1503.
-
(2008)
Lancet
, vol.371
, Issue.9623
, pp. 1502-3
-
-
Gray, R.1
-
120
-
-
34248585127
-
Chemotherapy or No Chemotherapy in Clear Margins after Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: CHRONICLE. A Randomised Phase III Trial of Control vs. Capecitabine plus Oxaliplatin
-
DOI 10.1016/j.clon.2007.03.003, PII S0936655507005407
-
Glynne-Jones R,Meadows H,Wood W. Chemotherapy or no chemotherapy in clear margins after neoadjuvant chemoradiation in locally advanced rectal cancer: CHRONICLE - a randomised phase III trial of control vs capecitabine plus oxaliplatin. Clin Oncol (R Coll Radiol) 2007; 19 (5): 327-9. (Pubitemid 46760601)
-
(2007)
Clinical Oncology
, vol.19
, Issue.5
, pp. 327-329
-
-
Glynne-Jones, R.1
Meadows, H.2
Wood, W.3
-
121
-
-
79959729595
-
Safety analysis of the French Intergroup R98 trial comparing 5FU-leucovorin alone or with irinotecan in resected stages II-III rectal cancers [ abstract no. 4088]
-
for AERO, GERCOR, FFCD and FNCLCC
-
Piedbois P, Ychou M, Zawadi A, et al., for AERO, GERCOR, FFCD and FNCLCC. Safety analysis of the French Intergroup R98 trial comparing 5FU-leucovorin alone or with irinotecan in resected stages II-III rectal cancers [abstract no. 4088]. J Clin Oncol 2008; 26 Suppl.: 4088.
-
(2008)
J Clin Oncol
, vol.26
, Issue.SUPPL. 4088
-
-
Piedbois, P.1
Ychou, M.2
Zawadi, A.3
-
122
-
-
35348841498
-
Adjuvant management of rectal cancer: The more we learn, the less we know
-
DOI 10.1200/JCO.2007.12.8892
-
Minsky BD. Adjuvant management of rectal cancer: the more we learn, the less we know. J Clin Oncol 2007; 25 (28): 4339-40. (Pubitemid 350013835)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.28
, pp. 4339-4340
-
-
Minsky, B.D.1
-
123
-
-
36749097684
-
ECOG E3201:Intergroup randomized phase III study of postoperative irinotecan, 5-fluorouracil (FU), leucovorin (LV) (FOLFIRI) versus oxaliplatin FU/LV (FOLFOX) vs FU/LV for patients with stage II/III rectal cancer receiving either pre- or postoperative radiation (RT)/FU [abstract]
-
18 S Jun 20
-
Benson AB, Catalano PJ, Meropol NJ et al., ECOG E3201:Intergroup randomized phase III study of postoperative irinotecan, 5-fluorouracil (FU), leucovorin (LV) (FOLFIRI) versus oxaliplatin FU/LV (FOLFOX) vs FU/LV for patients with stage II/III rectal cancer receiving either pre- or postoperative radiation (RT)/FU [abstract]. J Clin Oncol Proc ASCO; 2006: 24,18S (Jun 20 Suppl.): 3526.
-
(2006)
J Clin Oncol Proc ASCO
, vol.24
, Issue.SUPPL.
, pp. 3526
-
-
Benson, A.B.1
Catalano, P.J.2
Meropol, N.J.3
-
124
-
-
77954399498
-
Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radiochemotherapy? A systematic review of randomised trials
-
Bujko K, Glynne-Jones R, Bujko M. Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radiochemotherapy? A systematic review of
-
(2010)
Ann Oncol
, vol.21
, Issue.9
, pp. 1743-1750
-
-
Bujko, K.1
Glynne-Jones, R.2
Bujko, M.3
-
125
-
-
0035922657
-
Adjuvant radiotherapy for rectal cancer: A systematic overview of 8507 patients from 22 randomised trials
-
Colorectal Cancer Collaborative Group
-
Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials. Lancet 2001; 358: 1291-304.
-
(2001)
Lancet
, vol.358
, pp. 1291-1304
-
-
-
126
-
-
0022969524
-
Preoperative radiation therapy for rectal cancer
-
Fortier GA, Constable WC, Meyers H, et al. Preoperative radiation therapy for rectal cancer. Arch Surg 1986; 121: 1380-4.
-
(1986)
Arch Surg
, vol.121
, pp. 1380-4
-
-
Fortier, G.A.1
Constable, W.C.2
Meyers, H.3
-
127
-
-
0034307087
-
Preoperative chemoradiotherapy and pelvic radiation for tethered or fixed rectal cancer: A phase II dose escalation study
-
Chan AK, Wong AO, Langevin J, et al. Preoperative chemoradiotherapy and pelvic radiation for tethered or fixed rectal cancer: a phase II dose escalation study. Int J Radiat Oncol Biol Phys 2000; 48 (3): 843-56.
-
(2000)
Int J Radiat Oncol Biol Phys
, vol.48
, Issue.3
, pp. 843-856
-
-
Chan, A.K.1
Wong, A.O.2
Langevin, J.3
-
128
-
-
0027527192
-
High-dose preoperative radiation for cancer of the rectum: Impact of radiation dose on patterns of failure and survival
-
Ahmad NR, Marks G, Mohiuddin M. High-dose preoperative radiation for cancer of the rectum: impact of radiation dose on patterns of failure and survival. Int J Radiat Oncol Biol Phys 1993; 27: 773-8. (Pubitemid 23340285)
-
(1993)
International Journal of Radiation Oncology Biology Physics
, vol.27
, Issue.4
, pp. 773-778
-
-
Ahmad, N.R.1
Marks, G.2
Mohiuddin, M.3
-
129
-
-
33644846430
-
Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation therapy oncology group trial 0012
-
DOI 10.1200/JCO.2005.03.6095
-
Mohiuddin M, Winter K, Mitchell E, et al. Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012. J Clin Oncol 2006; 24 (4): 650-5. (Pubitemid 46630429)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.4
, pp. 650-655
-
-
Mohiuddin, M.1
Winter, K.2
Mitchell, E.3
Hanna, N.4
Yuen, A.5
Nichols, C.6
Shane, R.7
Hayostek, C.8
Willett, C.9
-
130
-
-
31844451549
-
Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: Effect of dose escalation on pathologic complete response, local recurrence-free survival, disease-free survival, and overall survival
-
DOI 10.1016/j.ijrobp.2005.08.012, PII S0360301605023795
-
Wiltshire KL, Ward IG, Swallow C, et al. Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: effect of dose escalation on pathologic complete response, local recurrence-free survival, diseasefree survival, and overall survival. Int J Radiat Oncol Biol Phys 2006; 64 (3): 709-16. (Pubitemid 43183564)
-
(2006)
International Journal of Radiation Oncology Biology Physics
, vol.64
, Issue.3
, pp. 709-716
-
-
Wiltshire, K.L.1
Ward, I.G.2
Swallow, C.3
Oza, A.M.4
Cummings, B.5
Pond, G.R.6
Catton, P.7
Kim, J.8
Ringash, J.9
Wong, C.S.10
Wong, R.11
Siu, L.L.12
Moore, M.13
Brierley, J.14
-
131
-
-
0028586691
-
Adjuvant preoperative radiotherapy for locally advanced rectal carcinoma: Results of a prospective randomized trial
-
Marsh PH, James RD, Schofield PF. Adjuvant preoperative radiotherapy for locally advanced rectal carcinoma: results of a prospective randomized trial. Dis Colon Rectum 1994; 37 (12): 1205-14.
-
(1994)
Dis Colon Rectum
, vol.37
, Issue.12
, pp. 1205-1214
-
-
Marsh, P.H.1
James, R.D.2
Schofield, P.F.3
-
132
-
-
0041563993
-
The epidermal growth factor receptor mediates radioresistance
-
DOI 10.1016/S0360-3016(03)00511-X
-
Liang K, Ang KK, Milas L, et al. The epidermal growth factor receptor mediates radioresistance. Int J Radiat Oncol Biol Phys 2003; 57: 246-54. (Pubitemid 36959763)
-
(2003)
International Journal of Radiation Oncology Biology Physics
, vol.57
, Issue.1
, pp. 246-254
-
-
Liang, K.1
Ang, K.K.2
Milas, L.3
Hunter, N.4
Fan, Z.5
-
133
-
-
20944439836
-
Preoperative short-term radiation therapy (25 Gy, 2.5 Gy twice daily) for primary resectable rectal cancer (phase II)
-
DOI 10.1038/sj.bjc.6602485
-
Widder J, Herbst F, Dobrowsky W, et al. Preoperative short-term radiation therapy (25 Gy, 2.5 Gy twice daily) for primary resectable rectal cancer (phase II). Br J Cancer 2005; 92: 1209-14. (Pubitemid 40604393)
-
(2005)
British Journal of Cancer
, vol.92
, Issue.7
, pp. 1209-1214
-
-
Widder, J.1
Herbst, F.2
Dobrowsky, W.3
Schmid, R.4
Pokrajac, B.5
Jech, B.6
Chiari, C.7
Stift, A.8
Maier, A.9
Karner-Hanusch, J.10
Teleky, B.11
Wrba, F.12
Jakesz, R.13
Poetter, R.14
-
134
-
-
33751350511
-
Short course continuous, hyperfractionated, accelerated radiation therapy (CHART) as preoperative treatment for rectal cancer
-
DOI 10.1080/02841860600897900, PII H5N6366601005K8M
-
Brooks S, Glynne-Jones R, Novell R, et al. Short course continuous hyperfractionated accelerated radiotherapy (CHART) as pre-operative treatment for rectal cancer. Acta Oncol 2006; 45: 1079-85. (Pubitemid 44808494)
-
(2006)
Acta Oncologica
, vol.45
, Issue.8
, pp. 1079-1085
-
-
Brooks, S.1
Glynne-Jones, R.2
Novell, R.3
Harrison, M.4
Brown, K.5
Makris, A.6
-
135
-
-
33751343403
-
Effect of timing of surgery on survival after preoperative hyperfractionated accelerated radiotherapy (HART) for locally advanced rectal cancer (LARC): Is it a matter of days?
-
DOI 10.1080/02841860600891317, PII J864U8N3M157W144
-
Coucke PA, Notter M, Matter M, et al. Effective timing of surgery on survival after preoperative hyperfractionated accelerated radiotherapy (HART) for locally advanced rectal cancer (LARC). Is it a matter of days? Acta Oncol 2006; 45: 1086-93. (Pubitemid 44808495)
-
(2006)
Acta Oncologica
, vol.45
, Issue.8
, pp. 1086-1093
-
-
Coucke, P.A.1
Notter, M.2
Matter, M.3
Fasolini, F.4
Calmes, J.-M.5
Schlumpf, R.6
Schwegler, N.7
Stamm, B.8
Do, H.P.9
Bouzourene, H.10
-
136
-
-
74549137819
-
Prospective phase II study of preoperative short-course radiotherapy for rectal cancer with twice daily fractions of 2.9 Gy to a total dose of 29 Gy-long-term results
-
Guckenberger M, Wulf J, Thalheimer A, et al. Prospective phase II study of preoperative short-course radiotherapy for rectal cancer with twice daily fractions of 2.9 Gy to a total dose of 29 Gy-long-term results. Radiat Oncol 2009; 4: 67.
-
(2009)
Radiat Oncol
, vol.4
, pp. 67
-
-
Guckenberger, M.1
Wulf, J.2
Thalheimer, A.3
-
137
-
-
0025760289
-
Primary rectal cancer treated with high-dose-rate intraluminal brachytherapy following external radiotherapy
-
Kamikonya N, Hishikawa Y, Kurisu K, et al. Primary rectal cancer treated with high-dose-rate intraluminal brachytherapy following external radiotherapy. Radiat Med 1991; 9: 85-7.
-
(1991)
Radiat Med
, vol.9
, pp. 85-87
-
-
Kamikonya, N.1
Hishikawa, Y.2
Kurisu, K.3
-
138
-
-
18744391935
-
Conformal preoperative endorectal brachytherapy treatment for locally advanced rectal cancer: Early results of a phase I/II study
-
Vuong T, Belliveau PJ, Michel RP, et al. Conformal preoperative endorectal brachytherapy treatment for locally advanced rectal cancer: early results of a phase I/II study. Dis Colon Rectum 2002; 45: 1486-93.
-
(2002)
Dis Colon Rectum
, vol.45
, pp. 1486-1493
-
-
Vuong, T.1
Belliveau, P.J.2
Michel, R.P.3
-
139
-
-
0024428114
-
Remote afterloading intraluminal brachytherapy in the treatment of rectal, rectosigmoid, and anal cancer: A feasibility study
-
Kaufman N, Nori D, Shank B, et al. Remote afterloading intraluminal brachytherapy in the treatment of rectal, rectosigmoid, and anal cancer: a feasibility study. Int J Radiat Oncol Biol Phys 1989; 17: 663-8. (Pubitemid 19227572)
-
(1989)
International Journal of Radiation Oncology Biology Physics
, vol.17
, Issue.3
, pp. 663-668
-
-
Kaufman, N.1
Nori, D.2
Shank, B.3
Linares, L.4
Harrison, L.5
Fass, D.6
Enker, W.7
-
140
-
-
30544446264
-
Preoperative chemoradiation of locally advanced T3 rectal cancer combined with an endorectal boost
-
DOI 10.1016/j.ijrobp.2005.07.969, PII S0360301605022273
-
Jakobsen A, Mortensen JP, Bisgaard C, et al. Preoperative chemoradiation of locally advanced T3 rectal cancer combined with an endorectal boost. Int J Radiat Oncol Biol Phys 2006; 64: 461-5. (Pubitemid 43083433)
-
(2006)
International Journal of Radiation Oncology Biology Physics
, vol.64
, Issue.2
, pp. 461-465
-
-
Jakobsen, A.1
Mortensen, J.P.2
Bisgaard, C.3
Lindebjerg, J.4
Hansen, J.W.5
Rafaelsen, S.R.6
-
141
-
-
72449152132
-
High-dose-rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma
-
Corner C, Bryant L, Chapman C, et al. High-dose-rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma. Brachytherapy 2010; 9: 66-70.
-
(2010)
Brachytherapy
, vol.9
, pp. 66-70
-
-
Corner, C.1
Bryant, L.2
Chapman, C.3
-
142
-
-
2942750356
-
Improved sphincter preservation in low rectal cancer with high dose preoperative radiotherapy: The Lyon R96-02 randomised trial
-
Gerard JP, Chapet O, Nemoz C, et al. Improved sphincter preservation in low rectal cancer with high dose preoperative radiotherapy: the Lyon R96-02 randomised trial. J Clin Oncol 2004; 22: 2402-9.
-
(2004)
J Clin Oncol
, vol.22
, pp. 2402-9
-
-
Gerard, J.P.1
Chapet, O.2
Nemoz, C.3
-
143
-
-
77949413228
-
Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer
-
Pettersson D, Cedermark B, Holm T, et al. Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer. Br J Surg 2010; 97 (4): 580-7.
-
(2010)
Br J Surg
, vol.97
, Issue.4
, pp. 580-7
-
-
Pettersson, D.1
Cedermark, B.2
Holm, T.3
-
144
-
-
0032812135
-
Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: The Lyon R90-01 randomized trial
-
Francois Y, Nemoz CJ, Baulieux J, et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter sparing surgery for rectal cancer: the Lyon R90-01 randomised trial. J Clin Oncol 1999; 17: 2396-402. (Pubitemid 29368238)
-
(1999)
Journal of Clinical Oncology
, vol.17
, Issue.8
, pp. 2396-2402
-
-
Francois, Y.1
Nemoz, C.J.2
Baulieux, J.3
Vignal, J.4
Grandjean, J.-P.5
Partensky, C.6
Souquet, J.C.7
Adeleine, P.8
Gerard, J.-P.9
-
145
-
-
77954640754
-
Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes?
-
Sun Myint A, Mukhopadhyay T, Ramani VS, et al. Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes? Colorectal Dis 2010; 12 Suppl. 2: 30-6.
-
(2010)
Colorectal Dis
, vol.12
, Issue.SUPPL. 2
, pp. 30-36
-
-
Sun Myint, A.1
Mukhopadhyay, T.2
Ramani, V.S.3
-
146
-
-
0031727142
-
Endoluminal radiotherapy for rectal tumors
-
DOI 10.1159/000011906
-
Tanum G, Wiig J, Andersen OK. Endoluminal radiotherapy for rectal tumors. Oncology 1998; 55 (6): 521-4. (Pubitemid 28479109)
-
(1998)
Oncology
, vol.55
, Issue.6
, pp. 521-524
-
-
Tanum, G.1
Wiig, J.2
Andersen, O.K.3
-
147
-
-
0033064382
-
Selection criteria for treatment of rectal cancer with combined external beam and endocavitary radiation
-
Birnbaum EH, Ogunbiyi OA, Gagliardi G, et al. Selection criteria for treatment of rectal cancer with combined external beam and endocavitary radiation. Dis Colon Rectum 1999; 42: 727-33.
-
(1999)
Dis Colon Rectum
, vol.42
, pp. 727-733
-
-
Birnbaum, E.H.1
Ogunbiyi, O.A.2
Gagliardi, G.3
-
148
-
-
0034212424
-
Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer
-
DOI 10.1016/S0360-3016(00)00418-1, PII S0360301600004181
-
Janjan NA, Crane CN, Feig BW, et al. Prospective trial of preoperative concomitant boost radiotherapy with con- tinuous infusion 5-fluorouracil for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2000; 47 (3): 713-8. (Pubitemid 30317490)
-
(2000)
International Journal of Radiation Oncology Biology Physics
, vol.47
, Issue.3
, pp. 713-718
-
-
Janjan, N.A.1
Crane, C.N.2
Feig, B.W.3
Cleary, K.4
Dubrow, R.5
Curley, S.A.6
Ellis, L.M.7
Vauthey, J.-N.8
Lenzi, R.9
Lynch, P.10
Wolff, R.11
Brown, T.12
Pazdur, R.13
Abbruzzese, J.14
Hoff, P.M.15
Allen, P.16
Brown, B.17
Skibber, J.18
-
149
-
-
33748932854
-
Phase II study of capecitabine (Xeloda®) and concomitant boost radiotherapy in patients with locally advanced rectal cancer
-
DOI 10.1016/j.ijrobp.2006.05.063, PII S0360301606009849
-
Krishnan S, Janjan NA, Skibber JM, et al. Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2006; 66 (3): 762-71. (Pubitemid 44436703)
-
(2006)
International Journal of Radiation Oncology Biology Physics
, vol.66
, Issue.3
, pp. 762-771
-
-
Krishnan, S.1
Janjan, N.A.2
Skibber, J.M.3
Rodriguez-Bigas, M.A.4
Wolff, R.A.5
Das, P.6
Delclos, M.E.7
Chang, G.J.8
Hoff, P.M.9
Eng, C.10
Brown, T.D.11
Crane, C.H.12
Feig, B.W.13
Morris, J.14
Vadhan-Raj, S.15
Hamilton, S.R.16
Lin, E.H.17
-
150
-
-
0028850788
-
Intraoperative irradiation after palliative surgery for locally recurrent rectal cancer
-
Suzuki K, Gunderson LL, Devine RM, et al. Intraoperative irradiation after palliative surgery for locally recurrent rectal cancer. Cancer 1995; 75: 939-52.
-
(1995)
Cancer
, vol.75
, pp. 939-952
-
-
Suzuki, K.1
Gunderson, L.L.2
Devine, R.M.3
-
151
-
-
0032805185
-
Intraoperative irradiation after surgery for locally recurrent rectal cancer
-
Hashiguchi Y, Sekine T, Sakamoto H, et al. Intraoperative irradiation after surgery for locally recurrent rectal cancer. Dis Colon Rectum 1999; 42: 886-93.
-
(1999)
Dis Colon Rectum
, vol.42
, pp. 886-893
-
-
Hashiguchi, Y.1
Sekine, T.2
Sakamoto, H.3
-
152
-
-
77953965474
-
Results of European pooled analysis of IORT-containing multimodality treatment for locally advanced rectal cancer: Adjuvant chemotherapy prevents local recurrence rather than distant metastases
-
Kusters M, Valentini V, Calvo FA, et al. Results of European pooled analysis of IORT-containing multimodality treatment for locally advanced rectal cancer: adjuvant chemotherapy prevents local recurrence rather than distant metastases. Ann Oncol 2010; 21 (6): 1279-84.
-
(2010)
Ann Oncol
, vol.21
, Issue.6
, pp. 1279-1284
-
-
Kusters, M.1
Valentini, V.2
Calvo, F.A.3
-
153
-
-
0023220325
-
The future of external beam irradiation as initial treatment of rectal cancer
-
DOI 10.1002/bjs.1800740604
-
Papillon J. The future of external beam radiotherapy irradiation as initial treatment of rectal cancer. Br J Surg 1987; 74: 449-54. (Pubitemid 17085653)
-
(1987)
British Journal of Surgery
, vol.74
, Issue.6
, pp. 449-454
-
-
Papillon, J.1
-
154
-
-
0021964478
-
Interim analysis of a phase III study on preoperative radiation therapy in resectable rectal carcinoma. Trial of the Gastrointestinal Tract Cancer Cooperative Group of the European Organization for Research on Treatment of Cancer (EORTC)
-
DOI 10.1002/10 97-0142(19 850515)55:10<2 373::AID-C NCR2820551 012>3.0.CO;2-D
-
Gerard A, Berrod JL, Pene F, et al. Interim analysis of a phase III study on preoperative radiation therapy in resectable rectal carcinoma: trial of the Gastrointestinal Tract Cancer Cooperative Group of the European Organization for Research on Treatment of Cancer (EORTC). Cancer 1985; 55 (10): 2373-9. (Pubitemid 15115185)
-
(1985)
Cancer
, vol.55
, Issue.10
, pp. 2373-2379
-
-
Gerard, A.1
Berrod, J.-L.2
Pene, F.3
-
155
-
-
0015310743
-
Preoperative irradiation of rectosigmoid carcinoma including its regional lymph nodes
-
Kligerman MM, Urdaneta N, Knowlton A, et al. Preoperative irradiation of rectosigmoid carcinoma including its regional lymph nodes. Am J Roentgenol Radium Ther Nucl Med 1972; 114 (3): 498-503.
-
(1972)
Am J Roentgenol Radium Ther Nucl Med
, vol.114
, Issue.3
, pp. 498-503
-
-
Kligerman, M.M.1
Urdaneta, N.2
Knowlton, A.3
-
156
-
-
0017157946
-
Preoperative radiotherapy for adenocarcinoma of the rectosigmoid
-
Stevens Jr KR, Allen CV, Fletcher WS. Preoperative radiotherapy for adenocarcinoma of the rectosigmoid. Cancer 1976; 37 (6): 2866-74.
-
(1976)
Cancer
, vol.37
, Issue.6
, pp. 2866-2874
-
-
Stevens Jr., K.R.1
Allen, C.V.2
Fletcher, W.S.3
-
157
-
-
0022570109
-
A critical review of adjuvant preoperative radiation therapy for adenocarcinoma of the rectum
-
Cummings BJ. A critical review of adjuvant preoperative radiation therapy for adenocarcinoma of the rectum. Br J Surg 1986; 73 (5): 332-8. (Pubitemid 16112080)
-
(1986)
British Journal of Surgery
, vol.73
, Issue.5
, pp. 332-338
-
-
Cummings, B.J.1
-
158
-
-
0042889277
-
Long-term results of the Lyons R90-01 randomized trial of preoperative radiotherapy with delayed surgery and its effect on sphincter-saving surgery in rectal cancer
-
DOI 10.1002/bjs.4162
-
Glehen O, Chapet O, Adham M. Long-term results of the Lyon R90-01 randomized trial of preoperative radiotherapy with delayed surgery and its effect on sphincter-saving surgery in rectal cancer. Br J Surg 2003; 90: 996-8. (Pubitemid 37026330)
-
(2003)
British Journal of Surgery
, vol.90
, Issue.8
, pp. 996-998
-
-
Glehen, O.1
Chapet, O.2
Adham, M.3
Nemoz, J.C.4
Gerard, J.P.5
-
159
-
-
56749175048
-
Delaying surgery after neoadjuvant chemoradiotherapy for rectal cancer may reduce postoperative morbidity without compromising prognosis
-
Kerr SF, Norton S, Glynne-Jones R. Delaying surgery after neoadjuvant chemoradiotherapy for rectal cancer may reduce postoperative morbidity without compromising prognosis. Br J Surg 2008; 95: 1534-40.
-
(2008)
Br J Surg
, vol.95
, pp. 1534-1540
-
-
Kerr, S.F.1
Norton, S.2
Glynne-Jones, R.3
-
160
-
-
10744222992
-
Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection
-
DOI 10.1007/s10350-003-0062-1
-
Moore HG, Gittleman AE, Minsky BD, et al. Rate of pathological complete response with increased interval between preoperative combined modality therapy and rectal cancer resection. Dis Colon Rectum 2004; 47: 279-86. (Pubitemid 38280578)
-
(2004)
Diseases of the Colon and Rectum
, vol.47
, Issue.3
, pp. 279-286
-
-
Moore, H.G.1
Gittleman, A.E.2
Minsky, B.D.3
Wong, D.4
Paty, P.B.5
Weiser, M.6
Temple, L.7
Saltz, L.8
Shia, J.9
Guillem, J.G.10
-
161
-
-
33646421402
-
Negative influence of delayed surgery on survival after preoperative radiotherapy in rectal cancer
-
DOI 10.1111/j.1463-1318.2006.00990.x
-
Supiot S, Bennouna J, Rio E, et al. Negative influence of delayed surgery on survival after preoperative radiotherapy in rectal cancer. Colorectal Dis 2006; 8: 430-5. (Pubitemid 43676659)
-
(2006)
Colorectal Disease
, vol.8
, Issue.5
, pp. 430-435
-
-
Supiot, S.1
Bennouna, J.2
Rio, E.3
Meurette, G.4
Bardet, E.5
Buecher, B.6
Dravet, F.7
Le Neel, J.-C.8
Douillard, J.-Y.9
Mahe, M.-A.10
Lehur, P.-A.11
-
162
-
-
33750071992
-
Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: Prospective observational study
-
Mercury Group
-
Mercury Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 2006; 333 (7572): 779-84.
-
(2006)
BMJ
, vol.333
, Issue.7572
, pp. 779-784
-
-
-
163
-
-
33644819648
-
Low rectal cancer: A call for a change of approach in abdominoperineal resection
-
Nagtegaal ID, van de Velde CJH, Marijnen CAM, et al. Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol 2005; 23 (36): 9257-64.
-
(2005)
J Clin Oncol
, vol.23
, Issue.36
, pp. 9257-9264
-
-
Nagtegaal, I.D.1
Van De Velde Cjh2
Cam, M.3
-
164
-
-
34748861543
-
Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer
-
DOI 10.1007/s10350-007-277-7
-
Kim IL, Lim SB, Kang HC. Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer. Dis Colon Rectum 2007; 50: 1342-53. (Pubitemid 47472394)
-
(2007)
Diseases of the Colon and Rectum
, vol.50
, Issue.9
, pp. 1342-1353
-
-
Kim, I.-J.1
Lim, S.-B.2
Kang, H.C.3
Chang, H.J.4
Ahn, S.-A.5
Park, H.-W.6
Jang, S.-G.7
Park, J.-H.8
Kim, D.Y.9
Jung, K.H.10
Choi, H.S.11
Jeong, S.-Y.12
Sohn, D.K.13
Kim, D.-W.14
Park, J.-G.15
-
165
-
-
61649088414
-
Epidermal Growth Factor Receptor gene copy number KRAS mutation and pathological response to preoperative Cetuximab, 5FU and radiation therapy in locally advanced rectal cancer
-
Bengala C, Patelli S, Bertolini F, et al. Epidermal Growth Factor Receptor gene copy number KRAS mutation and pathological response to preoperative Cetuximab, 5FU and radiation therapy in locally advanced rectal cancer. Ann Oncol 2009; 20: 469-74.
-
(2009)
Ann Oncol
, vol.20
, pp. 469-474
-
-
Bengala, C.1
Patelli, S.2
Bertolini, F.3
-
166
-
-
38549120954
-
Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy
-
DOI 10.1038/sj.bjc.6604172, PII 6604172
-
Zlobec I, Vuong T, Compton CC, et al. Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy. Br J Cancer 2008; 98: 450-6. (Pubitemid 351161259)
-
(2008)
British Journal of Cancer
, vol.98
, Issue.2
, pp. 450-456
-
-
Zlobec, I.1
Vuong, T.2
Compton, C.C.3
Lugli, A.4
Michel, R.P.5
Hayashi, S.6
Jass, J.R.7
-
167
-
-
67651109072
-
The role of dual-time combined 18-fluorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery
-
Capirci C, Rubello D, Pasini F, et al. The role of dual-time combined 18-fluorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery. Int J Radiat Oncol Biol Phys 2009; 74 (5): 1461-9.
-
(2009)
Int J Radiat Oncol Biol Phys
, vol.74
, Issue.5
, pp. 1461-9
-
-
Capirci, C.1
Rubello, D.2
Pasini, F.3
-
168
-
-
78149361784
-
The use of PET in assessing tumor response after neoadjuvant chemoradiation for rectal cancer
-
Mak D, Joon DL, Chao M, et al. The use of PET in assessing tumor response after neoadjuvant chemoradiation for rectal cancer. Radiother Oncol 2010; 97 (2): 205-11.
-
(2010)
Radiother Oncol
, vol.97
, Issue.2
, pp. 205-211
-
-
Mak, D.1
Joon, D.L.2
Chao, M.3
-
169
-
-
77249154009
-
Evaluation of early metabolic responses in rectal cancer during combined radiochemotherapy or radiotherapy alone: Sequential FDG-PET-CT findings
-
Janssen MH, Ollers MC, van Stiphout RG, et al. Evaluation of early metabolic responses in rectal cancer during combined radiochemotherapy or radiotherapy alone: sequential FDG-PET-CT findings. Radiother Oncol 2010; 94 (2): 151-5.
-
(2010)
Radiother Oncol
, vol.94
, Issue.2
, pp. 151-5
-
-
Janssen, M.H.1
Ollers, M.C.2
Van Stiphout, R.G.3
-
170
-
-
41849147484
-
Technology Insight: Water diffusion MRI - A potential new biomarker of response to cancer therapy
-
DOI 10.1038/ncponc1073, PII NCPONC1073
-
Patterson DM, Padhani AR, Collins DJ. Technology insight: water diffusion MRI - a potential new biomarker of response to cancer therapy. Nat Clin Pract Oncol 2008; 5 (4): 220-33. (Pubitemid 351493681)
-
(2008)
Nature Clinical Practice Oncology
, vol.5
, Issue.4
, pp. 220-233
-
-
Patterson, D.M.1
Padhani, A.R.2
Collins, D.J.3
-
171
-
-
75349097963
-
Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: Preliminary analysis of diffusionweighted MR imaging for early detection of tumor histopathologic downstaging
-
Sun YS, Zhang XP, Tang L, et al. Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusionweighted MR imaging for early detection of tumor histopathologic downstaging. Radiology 2010; 254 (1): 170-8.
-
(2010)
Radiology
, vol.254
, Issue.1
, pp. 170-8
-
-
Sun, Y.S.1
Zhang, X.P.2
Tang, L.3
-
172
-
-
0036094194
-
Enhanced antitumor activity of anti-epidermal growth factor receptor monoclonal antibody IMC-C225 in combination with irinotecan (CPT-11) against human colorectal tumor xenografts
-
Prewett MC, Hooper AT, Bassi R, et al. Enhanced antitumor activity of anti-epidermal growth factor receptor monoclonal antibody IMC-C225 in combination with irinotecan (CPT-11) against human colorectal tumor xenografts. Clin Cancer Res 2002; 8: 994-1003. (Pubitemid 34517632)
-
(2002)
Clinical Cancer Research
, vol.8
, Issue.5
, pp. 994-1003
-
-
Prewett, M.C.1
Hooper, A.T.2
Bassi, R.3
Ellis, L.M.4
Waksal, H.W.5
Hicklin, D.J.6
-
173
-
-
0033561522
-
Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck
-
Huang SM, Bock JM, Harari PM. Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck. Cancer Res 1999; 59: 1935-40 (Pubitemid 29186168)
-
(1999)
Cancer Research
, vol.59
, Issue.8
, pp. 1935-1940
-
-
Huang, S.-M.1
Bock, J.M.2
Harari, P.M.3
|